tumours

Oncology

ASCO 2026 reshapes oncology trial design

The American Society of Clinical Oncology 2026 annual meeting showcased how, across tumour types, new cancer therapies are achieving deeper responses, extending survival and increasingly mo

R&D

Paving the road to functionally active antibody drugs

Antibody drugs have reshaped how we treat diseases.

Oncology

Harnessing IL-12: Immunotherapy research advances may enhanc...

While there have been many significant advances in healthcare in the past 25 years, including new treatments for cancer recurrence, more effective disease maintenance strategies, more preci

Oncology

Abstract illustration of targeting cancer cell

How automating flow cytometry is revolutionising cancer diag...

As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise.

Oncology

Elements in precision oncology

Validating the regulatory expectations on evidential requirements for predictive biomarkers is not a trivial process, but quite conceptually challenging.

Cancer